Zenas BioPharma, Inc. (ZBIO)
$31.65-1.98%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.0B
- Avg volume
- 746.5K
- Beta
- -1.01
- P/E (TTM)
- -3.29
- Short % float
- 112.31%
- Days to cover
- 13.8
- SI change
- -3.4%
- 1W
- +3.77%
- 1M
- +4.15%
- 3M
- +66.84%
- YTD
- -8.26%
- vs SPY 1W
- +4.96%
- vs SPY 1M
- +0.83%
- vs SPY 3M
- +64.45%
- vs SPY YTD
- -20.01%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
- RLAYBUYRelay Therapeutics, Inc.$4.5BBULLQ 4$20.74+1.65%
- AMLXBUYAmylyx Pharmaceuticals, Inc.$4.3BRECOVERYQ 10$38.60-1.32%
- TRVIBUYTrevi Therapeutics, Inc.$2.7BBULLQ 22$18.81+0.67%
- NTLABUYIntellia Therapeutics, Inc.$1.9BRECOVERYQ 3$13.28-2.18%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.8BRECOVERYQ 18$20.77-0.41%
- ORICBUYORIC Pharmaceuticals, Inc.$1.5BBULLQ 4$14.65-5.21%
- INBXBUYInhibrx Biosciences Inc.$1.5BRECOVERYQ 33$101.48+1.26%
- NVAXBUYNovavax, Inc.$1.4BRECOVERYQ 9$8.79-0.89%
- WVESELLWave Life Sciences Ltd.$1.1BCRISISQ 9$5.42-3.21%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 2
- GROWTH
- 0
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-113.8%
REV YoY-
ROE-189.7%
EPS YoY-
ROA-69.0%
GROSS-5973
OP-47557
NET-48438
[VALUATION]
P/E TTM-3.29
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B8.08
P/FCF-
EV/EBITDA-4.43
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E90.57
ALTMAN Z-
CURR RATIO9.93
ND/EBITDA-
BETA-1.01
